Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
December 8, 2005Journal of Clinical InvestigationOpen Access

 B-Crystallin is a novel oncoprotein that predicts poor clinical outcome in breast cancer

View Full Paper
Ask AI
Bookmark
Share

Authors

JMJosé V. Moyano

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

José V. Moyano (2005) studied this question.

synapsesocial.com/papers/6a7dd30f286d888403cdaddfhttps://doi.org/10.1172/jci25888
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1The Small Heat Shock Protein αB-crystallin Is a Novel Inhibitor of TRAIL-induced Apoptosis That Suppresses the Activation of Caspase-32005 · 211 citations
  2. 2Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications2001 · 11,083 citations